Australian Trade Mark Search

Australian Trade Mark Search is the Australian Government’s trade mark search system.

Additional fields:

Trade mark 2521449

IR number 1838889
Words CONECTA
Image
Image description
Status protected: Registered/protected
Priority date 25 Mar 2024 (Convention)
Classes 9, 42
Kind Word
Dates
Renewal due 24 Sep 2034
Registration advertised / published 05 May 2025
Entered on Register 05 May 2025
Acceptance advertised / published 28 Feb 2025
Acceptance 28 Feb 2025
IR notification 13 Feb 2025
Filing 24 Sep 2024
Registered from 24 Sep 2024

Owner Address for service
MONTAI THERAPEUTICS, INC.

IR Contact

Christina M. Licursi Wolf, Greenfield & Sacks, P.C.


Goods & Services
Class 9: Downloadable computer software for use in the pharmaceuticals and healthcare fields, namely, for the research and development of pharmaceutical products and chemical compounds, design of chemical structures, analysis and prediction of biological or chemical activity, and for analysis and prediction of compound in-vivo properties; downloadable computer software featuring machine learning and artificial intelligence for use in the pharmaceuticals and healthcare fields in connection with pharmaceutical drug discovery and development; downloadable computer software incorporating machine learning and artificial intelligence model for use in the field of pharmaceuticals and healthcare.
Class 42: Providing online non-downloadable software featuring machine learning and artificial intelligence for use in the field of healthcare; providing on-line non-downloadable software featuring machine learning and artificial intelligence for data analysis and data mining in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software featuring machine learning and artificial intelligence for drug and chemical analysis in drug discovery and development and for analysis and prediction of compound in-vivo properties; providing online non-downloadable software featuring machine learning and artificial intelligence for diagnostic and therapeutic use and drug response prediction; providing online non-downloadable software using artificial intelligence for use in the pharmaceutical field for discovering and designing compounds and small molecules; providing on-line non-downloadable software for the capture, collection, conversion, analysis, communication, processing, receiving, recording, storage and transmission of data, images, information and artificial intelligence in the fields of healthcare, biomedical and genomic research; providing on-line non-downloadable software incorporating artificial intelligence and machine learning models for collecting, analyzing, assessing, interpreting and predicting medical, health, transcriptional, genetic, genomic, pharmacogenomic, nutrigenomic, microbiomic, metabolomic, proteomic, biochemistry, and biomarker information, associations, conditions, outcomes, effects and risks; scientific research, namely, research and analysis services in the scientific fields of artificial intelligence and machine learning analytics, healthcare, biomedical and genomic research; scientific research, namely, research and analysis services using artificial intelligence and machine learning in the scientific fields of analytics, pharmaceutical, healthcare, biomedical and genomic research.

Convention details
Date 25 Mar 2024
Number 98466226
Country UNITED STATES OF AMERICA

Indexing constituents
Word Image